Recombinant Lactococcus lactis expressing anti-SARS-CoV-2-nanobodies blocks entry of the virus into human cells.
Abstract
Engineered probiotic bacteria with nanobodies surface display were constructed to inhibit viral proteins.
Keywords:
Lactococcus lactis, protein surface display, bacterial therapy, biochemistry, synthetic biology
Status
Graduate
Department
Chemistry & Biochemistry
College
College of Arts and Sciences
Campus
Athens
Faculty Mentor
Han, Yong
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.
COinS
Recombinant Lactococcus lactis expressing anti-SARS-CoV-2-nanobodies blocks entry of the virus into human cells.
Engineered probiotic bacteria with nanobodies surface display were constructed to inhibit viral proteins.